DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

12.81 0.37 (2.97%)

REAL-TIME: Last trade at

Extended Hours: $12.66 -$0.15 (-1.13%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

VNDA $12.81 2.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.43
Previous Close $12.44
Daily Range $12.31 - $12.91
52-Week Range $8.34 - $19.25
Market Cap $434.3M
P/E Ratio -7.40
Dividend (Yield) $0.00 (0.0%)
Volume 600,087
Average Daily Volume 503,174
Current FY EPS -$1.56

Sector

Healthcare

Industry

Drugs

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/

News & Commentary Rss Feed

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

Use Options For a Chance To Buy VNDA at a 30% Discount

Commit To Buy Vanda Pharmaceuticals At $7, Earn 15% Using Options

Twitter Takes A Tumble As Ability To Innovate Comes Into Question

Vanda Pharmaceuticals (VNDA) Strong On High Relative Volume Today

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2014 Results - Earnings Call Transcrip

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Vanda Pharmaceuticals (VNDA) Q3 2014 Results - Earnings Call Webcast

Sector Update: Health-Care Shares Flat Before Opening Bell

Sector Update: Health Care

Benzinga's Top #PreMarket Gainers

See More VNDA News...

VNDA's Top Competitors

VNDA $12.81 (2.97%)
Current stock: VNDA
AMGN $163.48 (2.53%)
Current stock: AMGN
GILD $102.40 (1.93%)
Current stock: GILD
BIIB $332.89 (2.39%)
Current stock: BIIB